| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/12/1995 | EP0647449A1 Sustained-release preparation of anti-endothelin substance |
| 04/12/1995 | EP0647444A1 L-2-oxothiazolidine-4-carboxylate and other stimulators of intracellular glutathione synthesis for reducing or preventing bone marrow hypoplasia |
| 04/12/1995 | EP0647275A1 Cloning and expression of gonadotropin-releasing hormone receptor |
| 04/12/1995 | EP0647274A1 Recombinant baculoviruses containing insect cellular promoter |
| 04/12/1995 | EP0647272A1 Anti-hiv proteins gap 31, dap 30 and dap 32, dna coding therefor and therapeutic uses thereof |
| 04/12/1995 | EP0647270A1 Novel malignant cell type markers of the interior nuclear matrix |
| 04/12/1995 | EP0647266A1 D-enzyme compositions and methods of their use |
| 04/12/1995 | EP0647239A1 Angiotensin iv peptides and receptor |
| 04/12/1995 | EP0647238A1 INTERLEUKIN-1$g(b) DELETION MUTANT |
| 04/12/1995 | EP0647237A1 Double chain peptide compounds having hemoregulatory activity |
| 04/12/1995 | EP0647236A1 Endothelin antagonists ii |
| 04/12/1995 | EP0647139A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) |
| 04/12/1995 | EP0647138A1 Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same |
| 04/12/1995 | EP0647131A1 Dermatological agent for aiding oxygen transport in the skin. |
| 04/12/1995 | EP0647129A1 Topical application composition. |
| 04/12/1995 | EP0561827B1 Tetrapeptides deriving from dalbaheptide antibiotics |
| 04/12/1995 | EP0511234B1 Stable injectible solutions for factor viii |
| 04/12/1995 | EP0478797B1 Novel physiologically active peptide originating in hog |
| 04/12/1995 | EP0383764B1 Bovine granulocyte-macrophage colony stimulating factor |
| 04/12/1995 | CN1101254A Novel compositions |
| 04/11/1995 | US5405957 Wavelength-specific photosensitive compounds and expanded porphyrin-like compounds and methods of use |
| 04/11/1995 | US5405946 Anticoagulants |
| 04/11/1995 | US5405945 DNA encoding reproductive hormones and expression using a minigene |
| 04/11/1995 | US5405942 Prepro insulin-like growth factors I and II |
| 04/11/1995 | US5405941 Gene therapy; anticancer, antiinflammatory agents, autoimmune diseases, Alzheimers*s |
| 04/11/1995 | US5405940 Isolated nonapeptides derived from MAGE genes and uses thereof |
| 04/11/1995 | US5405854 Sulfonamidocarboxamides |
| 04/11/1995 | US5405852 Amide derivatives |
| 04/11/1995 | US5405835 Including lactoserum minipeptides, casein minipeptides, casein minipeptides without phosphopeptides, in amounts to balance levels of sulfur-containing amino acids and protein-bound phosphorus |
| 04/11/1995 | US5405834 Prodrug derivatives of thyrotropin-releasing hormone (TRH) |
| 04/11/1995 | US5405832 Method of treating non-streptococcal bacterial infections |
| 04/11/1995 | US5405831 Administering amylin, a pancreatic-hormone polypeptide, and a carrier; osteoporosis; Paget's disease; hypercalcemia |
| 04/11/1995 | US5405785 Derivatives of cyclosporine A, antibodies directed thereto and uses thereof |
| 04/11/1995 | US5405771 Tissue plasminogen activator having zymogenic or fibrin specific properties |
| 04/11/1995 | US5405758 DNA encoding the recombinant 40 kDA Dermatophagoides farinae allergen |
| 04/11/1995 | US5405757 Synthesis of human procollagens and collagens in recombinant DNA systems |
| 04/11/1995 | US5405750 Detection and measurement of cellular complex between antibody and growth factor receptor, for diagnosis of immune system disorders |
| 04/11/1995 | US5405742 Contains purge and maintenance solutions; infusing organ to be transplanted with maintenance solution |
| 04/11/1995 | US5405607 Method for preparing fibrinogen adhesive from whole blood |
| 04/11/1995 | CA1335177C Inductive collagen-based bone repair preparation |
| 04/11/1995 | CA1335176C Gamma interferon formulation |
| 04/11/1995 | CA1335175C Methods and compositions for the treatment of lung conditions |
| 04/06/1995 | WO1995009365A1 Methods and compositions for treatment of bcr-abl associated leukemias and other cell proliferative disorders |
| 04/06/1995 | WO1995009241A2 Anti-cancer gene therapy by modulation of immune or inflammatory response |
| 04/06/1995 | WO1995009236A1 USING ANTISENSE OLIGONUCLEOTIDES TO MODULATE NERVE GROWTH AND TO REVERSE β/A4 AMYLOID-INDUCED MORPHOLOGY |
| 04/06/1995 | WO1995009232A2 Peptides representing epitopic sites for bacterial and viral meningitis causing agents and their cns carrier, antibodies thereto, and uses thereof |
| 04/06/1995 | WO1995009188A1 Antithrombotic |
| 04/06/1995 | WO1995009186A1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas |
| 04/06/1995 | WO1995009185A1 Novel peptide, active as inhibitors of platelet aggregation |
| 04/06/1995 | WO1995009184A1 Use of relaxin as an analgesic and palliative for intractable pain |
| 04/06/1995 | WO1995009183A1 Peptide and antithrombotic agent |
| 04/06/1995 | WO1995009182A1 Protective antigens against parasites |
| 04/06/1995 | WO1995009181A1 Peptide containing amino acid sequence of fimbrial protein of porphyromonas gingivalis and use thereof |
| 04/06/1995 | WO1995009180A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 04/06/1995 | WO1995009149A1 Anthracene derivatives for use as anticancer agent or dye |
| 04/06/1995 | WO1995009025A1 VACCINE FOR $i(BRANHAMELLA CATARRHALIS) |
| 04/06/1995 | WO1995009011A1 Methods of stimulating phagocytosis |
| 04/06/1995 | WO1995009005A1 Methods for stimulating interleukin-6 synthesis and inducing thrombocytopoiesis using oncostatin m |
| 04/06/1995 | WO1995009004A1 Compositions containing growth factors and antiplastic agents |
| 04/06/1995 | WO1995009003A1 Compositions containing growth factors and antimetabolites |
| 04/06/1995 | WO1995009002A1 Methods of inhibiting phagocytosis |
| 04/06/1995 | WO1995009001A1 Inhibitors of farnesyl-protein transferase |
| 04/06/1995 | WO1995009000A1 Inhibitors of farnesyl-protein transferase |
| 04/06/1995 | WO1995008999A1 AMELIORATION OF AMNESIA IN ALZHEIMER'S DISEASE CAUSED BY DEPOSITION OF AMYLOID β PROTEIN |
| 04/06/1995 | WO1995008996A1 Method for treatment of eosinophil-associated conditions |
| 04/06/1995 | WO1995006744A3 Methods of suppressing immune response by gene therapy |
| 04/06/1995 | WO1995006718A3 Methods of suppressing autoimmune response |
| 04/06/1995 | WO1995006717A3 Methods of suppressing graft rejection |
| 04/06/1995 | WO1995003417A3 Homologously recombinant slow growing mycobacteria and uses therefor |
| 04/06/1995 | EP0667871A4 Biologically active amphiphilic peptide compositions and uses therefor. |
| 04/06/1995 | CA2172961A1 Methods and compositions for treatment of bcr-abl associated leukemias and other cell proliferative disorders |
| 04/06/1995 | CA2172958A1 Anthracene derivatives for use as anticancer agent or dye |
| 04/06/1995 | CA2172808A1 Methods for stimulating interleukin-6 synthesis and inducing thrombocytopoiesis using oncostatin m |
| 04/06/1995 | CA2172729A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 04/06/1995 | CA2172728A1 Vaccine for branhamella catarrhalis |
| 04/06/1995 | CA2172492A1 Protective antigens against parasites |
| 04/06/1995 | CA2172393A1 Methods of stimulating phagocytosis |
| 04/06/1995 | CA2172126A1 Inhibitors of farnesyl-protein transferase |
| 04/06/1995 | CA2172125A1 Inhibitors of farnesyl-protein transferase |
| 04/06/1995 | CA2171553A1 Using antisense oligonucleotides to modulate nerve growth and to reverse .beta./a4 amyloid-induced morphology |
| 04/06/1995 | CA2149657A1 Compositions containing growth factors and antiplastic agents |
| 04/06/1995 | CA2149627A1 Amelioration of amnesia in alzheimer's disease caused by deposition of amyloid .beta. protein |
| 04/06/1995 | CA2149528A1 Compositions containing growth factors and antimetabolites |
| 04/06/1995 | CA2133002A1 Method of regulating blood amino acid levels |
| 04/05/1995 | EP0646649A1 Method of producing iturin A and antifungal agent for profund mycosis |
| 04/05/1995 | EP0646646A2 Protein expression system |
| 04/05/1995 | EP0646643A1 Modified human granulocyte macrophage-colony stimulating factor gene and expression thereof in yeast |
| 04/05/1995 | EP0646601A1 Motilin-like polypeptides with gastrointestinal motor stimulating activity |
| 04/05/1995 | EP0646600A1 A cell growth-inhibiting protein |
| 04/05/1995 | EP0646598A1 New pseudopeptides with antiviral activity containing valine |
| 04/05/1995 | EP0646597A1 New pseudopeptides with antiviral activity containing valine |
| 04/05/1995 | EP0646596A1 Nucleic acid binding oligomers having C-branches for therapy and diagnosis |
| 04/05/1995 | EP0646595A1 Nucleic acid binding oligomers having C-branches for therapy and diagnosis |
| 04/05/1995 | EP0646379A1 Insulin formulation |
| 04/05/1995 | EP0646377A1 Albumin-conjugated tumour cell-free extracts, antigenic compositions comprising the same, related antibodies, and uses thereof |
| 04/05/1995 | EP0646375A1 Method of regulating blood amino acid levels |
| 04/05/1995 | EP0646178A1 expression cassette with regularoty regions functional in the mammmlian host |
| 04/05/1995 | EP0646176A1 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| 04/05/1995 | EP0646175A1 RECOMBINANT $i(PSEUDOMONAS) EXOTOXIN WITH INCREASED ACTIVITY |
| 04/05/1995 | EP0646171A1 Improved expression of human multidrug resistance genes and improved selection of cells transduced with such genes |